Ibrilparant is a LPA1 receptor antagonist with an IC 50 of 0.00753 μM. Ibrilparant exhibits LPA1 calcium flux antagonistic activity, with an IC 50 of 3.02 nM. Ibrilparant can be used in research related to various diseases such as cancer and inflammatory diseases.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.